Hixon Zuercher’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Hold |
1,789
| – | – | 0.45% | 65 |
|
|
2025
Q1 | $1.48M | Buy |
1,789
+12
| +0.7% | +$9.91K | 0.52% | 62 |
|
|
2024
Q4 | $1.37M | Hold |
1,777
| – | – | 0.53% | 60 |
|
|
2024
Q3 | $1.57M | Buy |
1,777
+3
| +0.2% | +$2.66K | 0.62% | 54 |
|
|
2024
Q2 | $1.61M | Buy |
1,774
+12
| +0.7% | +$10.9K | 0.68% | 47 |
|
|
2024
Q1 | $1.37M | Sell |
1,762
-400
| -19% | -$311K | 0.58% | 51 |
|
|
2023
Q4 | $1.26M | Sell |
2,162
-26
| -1% | -$15.2K | 0.58% | 46 |
|
|
2023
Q3 | $1.18M | Hold |
2,188
| – | – | 0.62% | 45 |
|
|
2023
Q2 | $1.03M | Hold |
2,188
| – | – | 0.52% | 49 |
|
|
2023
Q1 | $751K | Sell |
2,188
-36
| -2% | -$12.4K | 0.45% | 43 |
|
|
2022
Q4 | $814K | Hold |
2,224
| – | – | 0.5% | 42 |
|
|
2022
Q3 | $719K | Sell |
2,224
-6,078
| -73% | -$1.96M | 0.46% | 46 |
|
|
2022
Q2 | $2.69M | Sell |
8,302
-993
| -11% | -$322K | 1.74% | 28 |
|
|
2022
Q1 | $2.66M | Sell |
9,295
-273
| -3% | -$78.2K | 1.43% | 32 |
|
|
2021
Q4 | $2.64M | Buy |
9,568
+162
| +2% | +$44.8K | 1.33% | 35 |
|
|
2021
Q3 | $2.17M | Buy |
9,406
+24
| +0.3% | +$5.55K | 1.27% | 35 |
|
|
2021
Q2 | $2.15M | Sell |
9,382
-8
| -0.1% | -$1.84K | 1.3% | 35 |
|
|
2021
Q1 | $1.75M | Buy |
9,390
+105
| +1% | +$19.6K | 1.16% | 32 |
|
|
2020
Q4 | $1.57M | Sell |
9,285
-102
| -1% | -$17.2K | 1.09% | 32 |
|
|
2020
Q3 | $1.39M | Buy |
9,387
+172
| +2% | +$25.5K | 1.07% | 32 |
|
|
2020
Q2 | $1.51M | Buy |
9,215
+7,065
| +329% | +$1.16M | 1.3% | 30 |
|
|
2020
Q1 | $298K | Hold |
2,150
| – | – | 0.43% | 29 |
|
|
2019
Q4 | $283K | Buy |
+2,150
| New | +$283K | 0.27% | 47 |
|